Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.135
-0.165 (-5.00%)
At close: Jul 18, 2025, 4:00 PM
3.130
-0.005 (-0.16%)
After-hours: Jul 18, 2025, 4:20 PM EDT

Cytek Biosciences Stock Forecast

Stock Price Forecast

The 4 analysts that cover Cytek Biosciences stock have a consensus rating of "Hold" and an average price target of $6, which forecasts a 91.39% increase in the stock price over the next year. The lowest target is $3 and the highest is $8.

Price Target: $6 (+91.39%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$3.00$6.00$7.00$8.00
Change-4.31%+91.39%+123.29%+155.18%
* Price targets were last updated on May 28, 2025.

Analyst Ratings

The average analyst rating for Cytek Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy100000
Buy222222
Hold000111
Sell000000
Strong Sell000111
Total322444

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Hold
Maintains
$9$7
HoldMaintains$9$7+123.29%May 28, 2025
Goldman Sachs
Goldman Sachs
Strong Sell
Maintains
$3.5$3
Strong SellMaintains$3.5$3-4.31%May 12, 2025
Stephens & Co.
Stephens & Co.
Buy
Reiterates
$6
BuyReiterates$6+91.39%Mar 19, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$8.5$8
BuyMaintains$8.5$8+155.18%Mar 4, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$8$8.5
BuyMaintains$8$8.5+171.13%Nov 11, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
202.27M
from 200.45M
Increased by 0.91%
Revenue Next Year
217.95M
from 202.27M
Increased by 7.75%
EPS This Year
-0.22
from -0.05
EPS Next Year
-0.16
from -0.22
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
92.84M127.95M164.04M193.02M200.45M202.27M217.95M248.94M
Revenue Growth
60.39%37.82%28.20%17.67%3.85%0.91%7.75%14.22%
EPS
0.100.000.02-0.09-0.05-0.22-0.16-0.10
EPS Growth
--99.36%2,906.28%-----
Forward PE
--------
No. Analysts
-----775
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High209.6M234.1M273.2M
Avg202.3M218.0M248.9M
Low192.1M196.7M228.7M

Revenue Growth

Revenue Growth202520262027
High
4.6%
15.8%
25.4%
Avg
0.9%
7.8%
14.2%
Low
-4.2%
-2.8%
4.9%

EPS Forecast

EPS202520262027
High-0.09-0.07-0.06
Avg-0.22-0.16-0.10
Low-0.31-0.21-0.14

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.